Search results

  1. SNT Gatchaman

    Internal medicine at the crossroads of long COVID diagnosis and management, 2025, Ranque and Cogan

    Following the section "A critical approach to the literature" :( is the section "Arguments for a functional disorder" — [34] is of course Interventions for the management of long covid post-covid condition: living systematic review (2024, BMJ)
  2. SNT Gatchaman

    Internal medicine at the crossroads of long COVID diagnosis and management, 2025, Ranque and Cogan

    Internal medicine at the crossroads of long COVID diagnosis and management Ranque, Brigitte; Cogan, Elie The lack of specificity in its definition is a major obstacle to both explanatory and therapeutic research in long COVID. It brings together, on the one hand, patients with severe COVID-19...
  3. SNT Gatchaman

    ME/CFS as a biological information processing problem

    I was having a look through things in relation to Jo's comment here on NKs and MAITs. On MAITs, this recently revised preprint BioMapAI: Artificial Intelligence Multi-Omics Framework Modeling of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (2025, Preprint: BioRxiv) may be worth a look...
  4. SNT Gatchaman

    Sympathetic Neural Overdrive, Vascular Dysfunction and Diminished Exercise Capacity in [LC]: A Long-Term Study of Cardiovascular Sequelae, 2025, Ono+

    Sympathetic Neural Overdrive, Vascular Dysfunction and Diminished Exercise Capacity in Long COVID-19 Patients: A Long-Term Study of Cardiovascular Sequelae Bruna E. Ono; João E. Izaias; Artur O. Sales; Thais S. Rodrigues; Camila S. Nunes; Jessica F. Niec; Natalia G. Rocha; Helena N.M. Rocha...
  5. SNT Gatchaman

    Deep Immunophenotyping in ME/CFS Using Spectral Flow Cytometry, 2025, Gibson, Brooks et al.

    In the data analysis section (summary emphasis added) —
  6. SNT Gatchaman

    Deep Immunophenotyping in ME/CFS Using Spectral Flow Cytometry, 2025, Gibson, Brooks et al.

    In the introductory section of this chapter, with some emphasis added for summary —
  7. SNT Gatchaman

    Deep Immunophenotyping in ME/CFS Using Spectral Flow Cytometry, 2025, Gibson, Brooks et al.

    While the chapters in this book are focused on methodologies and directed at researchers, there are passages that are worth posting so we understand the data when presented. Here for example how to look at "high dimensional flow cytometry" figures.
  8. SNT Gatchaman

    Preprint Dissecting the genetic complexity of myalgic encephalomyelitis/chronic fatigue syndrome via deep learning-powered genome analysis, 2025, Zhang+

    I quickly asked my friendly neighbourhood AI that exact question (I didn't mention eg S100PBP) and got the following response. That suggests the reutilisation of genes in other tissues, that Jonathon mentioned recently. Although in this case maybe just different regulation rather than different...
  9. SNT Gatchaman

    LEF1-AS1 Deregulation in the Peripheral Blood of Patients with Persistent Post-COVID Symptoms, 2025, Madè et al.

    LEF1 is Lymphoid Enhancer Binding Factor 1 LEF1-AS1 is LEF1 Antisense RNA 1 GeneCards — LEF1 LEF1-AS1
  10. SNT Gatchaman

    LEF1-AS1 Deregulation in the Peripheral Blood of Patients with Persistent Post-COVID Symptoms, 2025, Madè et al.

    LEF1-AS1 Deregulation in the Peripheral Blood of Patients with Persistent Post-COVID Symptoms Madè, Alisia; Piella, Santiago Nicolas; Ranucci, Marco; Gaetano, Carlo; Renna, Laura Valentina; Cardani, Rosanna; Spinetti, Gaia; Milani, Valentina; Martelli, Fabio Long COVID denotes the persistence...
  11. SNT Gatchaman

    PolyBio Spring 2025 Symposium

    Particularly as it may well turn out that the answers for LC actually come from ME/CFS research (including DecodeME and friends).
  12. SNT Gatchaman

    Cortisol levels in ME/CFS

    Non-significantly higher in Self-reported health, neuropsychological tests and biomarkers in fully recovered COVID-19 patients vs patients with post-COVID cognitive symptoms: A pilot study (2025, PLOS ONE)
  13. SNT Gatchaman

    Self-reported health, neuropsychological tests & biomarkers in fully recovered COVID-19 pts vs pts with post-COVID cognitive symptoms,2025,

    They also looked at BDNF, NfL and cortisol in plasma and serum, finding no group differences. Though cortisol was non-significantly higher in LC. LC Plasma = 81.38 Serum = 70.09 HC Plasma = 64.52 Serum = 61.29
  14. SNT Gatchaman

    Patients with severe ME/CFS need hope and expert multidisciplinary care, 2025, Miller et al

    Currently there are four, though I believe another group response may be inbound: https://www.bmj.com/content/389/bmj.r977/rr (Suzy J Evans) https://www.bmj.com/content/389/bmj.r977/rr-2 (Katharine A Cheston) https://www.bmj.com/content/389/bmj.r977/rr-3 (Michiel Tack)...
  15. SNT Gatchaman

    Multicentre retrospective detection of nailfold videocapillaroscopy abnormalities in long covid patients, 2025, Ginaldi et al.

    Thank you, that's both interesting and more than a little reassuring. My most recent employment eye assessment had also shown perfect retinal capillary appearances. The technique itself looks relatively straightforward and the only thing I'm unable to do currently is make measurements with a...
  16. SNT Gatchaman

    Patients with severe ME/CFS need hope and expert multidisciplinary care, 2025, Miller et al

    A response from the alternative medicine practitioners: Rebecca Kennedy, family medicine physician and lead of the long COVID clinic at a large health system :( That first sentence with the giveaway "CFS/ME". We've commented previously about the need for research into the psychology of...
Back
Top Bottom